Track topics on Twitter Track topics that are important to you
Harrow Health (NASDAQ:IMMY) announced it has formally changed its name and that it will trade as “HROW” on The NASDAQ Capital Markets beginning at market open January 2, 2019. As quoted in the press release: Mark L. Baum, CEO of Harrow Health, stated, “Our new name reflects our business model of creating, investing in, operating … Continued
The post Imprimis Pharmaceuticals Completes Name Change to Harrow Health appeared first on Investing News Network.
Original Article: Imprimis Pharmaceuticals Completes Name Change to Harrow HealthNEXT ARTICLE